病毒清除市場規模、佔有率、成長分析、按類型、按應用、按最終用戶、按方法、按地區 - 行業預測，2024-2031 年

2022年全球病毒清除市場規模為4929億美元，從2023年的5722.6億美元成長到2031年的18890.7億美元，在預測期內（2024-2031年）預計複合年成長率為16.1。

由於在生產單株抗體、重組蛋白、糖蛋白和其他生技藥品時迫切需要去除病毒顆粒和 TSE 病原體，病毒清除市場正在受到關注。這些產品面臨多種污染物的風險，包括病毒、細菌和真菌，因此強力的病毒安全措施至關重要。此外，對疫苗和生物治療藥物的需求不斷成長，以及製藥和生物技術領域投資的增加，也推動了市場的成長。由於製造商優先考慮病毒清除以確保產品的完整性和安全性，病毒清除過程的整體狀況將在未來幾年繼續發生變化，強調對生物過程的合規性和有效性的關鍵關注，預計在未來幾年將發生重大變化。

目錄

介紹

• 研究目的
• 調查範圍
• 定義

調查方法

• 資訊採購
• 二手資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制因素和挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2023）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 價格分析
• 技術進步

病毒清除市場規模：依方法及複合年成長率（2024-2031）

• 市場概況
• 病毒清除方法
  • 層析法
  • 濾
  • 沉澱
• 病毒去活化方法
  • PH值變化
  • 清潔劑（S/D）
  • 消毒
  • 乾熱
  • 其他
• 病毒檢測方法
  • 次世代定序（NGS）
  • 聚合酵素鏈鎖反應(PCR)
  • 體內測定
  • 體外測定

病毒清除市場規模：依應用和複合年成長率（2024-2031）

• 市場概況
• 血液和血液製品
• 重組蛋白
• 細胞/基因療法產品
• 疫苗

病毒清除市場規模：依最終用戶和複合年成長率（2024-2031）

• 市場概況
• 製藥和生物技術產業
• 學術研究所
• CRO

病毒清除市場規模：依地區及複合年成長率（2024-2031）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭資訊

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2023）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分類的佔有率分析
  • 收益與前一年同期比較（2021-2023）

主要企業簡介

• Charles River Laboratories
• Merck KGaA
• Texcell
• WuXi AppTec
• Sartorius AG
• Eurofins Scientific
• Vironova
• Syngene International
• Microbac Laboratories
• Creative Biolabs
• Nelson Labs
• SGS AG
• Lonza Group
• Bioscience Laboratories
• Labor Dr. Merk & Kollegen
• Gilead Sciences
• Poolbeg Pharma
• Incyte
• Genmab
• Biogen

結論和建議

Global Viral Clearance Market size was valued at USD 492.9 billion in 2022 and is poised to grow from USD 572.26 billion in 2023 to USD 1889.07 billion by 2031, growing at a CAGR of 16.1% during the forecast period (2024-2031).

The viral clearance market is gaining traction due to the essential need for eliminating viral particles and TSE agents during the production of monoclonal antibodies, recombinant proteins, glycoproteins, and other biologics. As these products face risks from various contaminants, including viruses, bacteria, and fungi, robust viral safety practices are becoming imperative. Furthermore, the increasing investments in the pharmaceutical and biotechnology sectors, alongside a rising demand for vaccines and biotherapeutic agents, are propelling growth in this market. As manufacturers prioritize viral clearance to ensure product integrity and safety, the overall landscape of viral clearance processes is expected to evolve significantly in the coming years, highlighting the critical focus on compliance and efficacy in bioprocessing.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Viral Clearance market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Viral Clearance Market Segmental Analysis

Global Viral Clearance Market is segmented by method, application, end-user and region. Based on method, the market is segmented into viral removal method, viral inactivation method and viral detection method. Based on application, the market is segmented into blood and blood products, recombinant proteins, cellular & gene therapy products and vaccines. Based on end-user, the market is segmented into pharmaceutical and biotech industry, academic research institutes and cros. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Viral Clearance Market

The global viral clearance market is primarily driven by the increasing demand for biologics and vaccines, which significantly enhances market growth. Regulatory agencies place a high priority on ensuring viral safety, requiring comprehensive assessments and high-quality data for Investigational New Drug (IND) and Biologics License Application (BLA) approvals. This necessitates expertise in relevant processes and regulatory compliance, which not only facilitates strategic planning but also leads to potential savings in time, resources, and finances. Moreover, the rising prevalence of chronic viral infections and the urgent need for effective treatment options, coupled with increased investments in the life sciences sector and the development of innovative therapies, further fuel market expansion.

Restraints in the Global Viral Clearance Market

The Global Viral Clearance market faces several restraints that hinder its growth, notably the significant expenses and a shortage of skilled professionals in the field. The advanced technologies required for viral clearance studies come with high costs, which can deter investment and development. Additionally, the overall operational and procedural expenses related to viral safety add to these financial burdens, further constraining the market. The increasing demand for expertise combined with this skill gap only exacerbates these challenges, leading to higher costs and ultimately limiting the market's potential for growth and expansion in the evolving landscape of viral safety solutions.

Market Trends of the Global Viral Clearance Market

The Global Viral Clearance market is experiencing significant growth driven by an escalating demand for generics and biosimilars. As healthcare systems globally strive for cost-effective treatment options for chronic diseases, there is heightened investment in recombinant non-glycosylated proteins, which serve as a cornerstone for developing biosimilars. This trend is fueled by advancements in technology that enhance viral clearance processes, ensuring safety and efficacy. Furthermore, regulatory pressures and the increasing prevalence of chronic health conditions propel the market forward, making efficient viral clearance methodologies crucial for pharmaceutical and biopharmaceutical companies. Overall, these dynamics are shaping a robust and evolving landscape in the viral clearance sector.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement

Global Viral Clearance Market Size by Method & CAGR (2024-2031)

• Market Overview
• Viral Removal Method
  • Chromatography
  • Filtration
  • Precipitation
• Viral Inactivation Method
  • Ph Modification
  • Solvent Detergent (S/D)
  • Pasteurization
  • Dry Heat
  • Others
• Viral Detection Method
  • Next Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • In Vivo Assay
  • In Vitro Assay

Global Viral Clearance Market Size by Application & CAGR (2024-2031)

• Market Overview
• Blood and Blood Products
• Recombinant Proteins
• Cellular & Gene Therapy Products
• Vaccines

Global Viral Clearance Market Size by End-User & CAGR (2024-2031)

• Market Overview
• Pharmaceutical and Biotech Industry
• Academic Research Institutes
• CROs

Global Viral Clearance Market Size & CAGR (2024-2031)

• North America (Method, Application, End-User)
  • USA
  • Canada
• Europe (Method, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Method, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Method, Application, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Method, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Charles River Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Texcell
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WuXi AppTec
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vironova
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Syngene International
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Microbac Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Biolabs
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nelson Labs
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SGS AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioscience Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Labor Dr. Merk & Kollegen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gilead Sciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Poolbeg Pharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Incyte
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genmab
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biogen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations